Block Listing Application

AI SummaryClose X

Shield Therapeutics has applied to the London Stock Exchange for admission to trading on AIM of 10,000,000 new ordinary shares of 1.5p each under an extension to its block listing for its Retention and Performance Share Plan; the new Ordinary Shares will be credited as fully paid and rank pari passu with existing shares, admission is expected on or around 25 November 2026, and issuance will occur only on option exercise and could dilute existing shareholders if exercised.

Disclaimer*

UK 100

Latest directors dealings